|
|
Volumn 55, Issue 9, 2010, Pages 926-927
|
|
Rosiglitazone Increases Myocardial Glucose Metabolism in Insulin-Resistant Cardiomyopathy
a
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EXENDIN 4;
FATTY ACID;
FLUORODEOXYGLUCOSE;
GLITAZONE DERIVATIVE;
GLUCOSE;
INSULIN;
INSULIN DERIVATIVE;
METFORMIN;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
ROSIGLITAZONE;
SITAGLIPTIN;
TRIMETAZIDINE;
CARDIAC PATIENT;
CONGESTIVE CARDIOMYOPATHY;
DIABETES MELLITUS;
DIZZINESS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG WITHDRAWAL;
FLUID RETENTION;
GLUCOSE BLOOD LEVEL;
GLUCOSE METABOLISM;
HEART FAILURE;
HEART MUSCLE METABOLISM;
HUMAN;
INSULIN BLOOD LEVEL;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LETTER;
MULTIDETECTOR COMPUTED TOMOGRAPHY;
ORAL GLUCOSE TOLERANCE TEST;
PILOT STUDY;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT OUTCOME;
ANIMALS;
CARDIOMYOPATHIES;
GLUCOSE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN RESISTANCE;
MYOCARDIUM;
THIAZOLIDINEDIONES;
VASODILATOR AGENTS;
|
|
EID: 76849083789
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jacc.2009.08.085 Document Type: Letter |
|
Times cited : (8)
|
|
References (6)
|
